( MENAFN - Daily News Egypt) Egypt's Ministry of health and Population announced the inclusion of a new immunotherapy drug to ...

With unprecedented advancements in technology and personalized medicine, the North America organoids and spheroids market is ...

Finally, the activated dendritic cells release signals that recruit natural killer cells and T cells ... After exhausting ...

Fibroblast growth factors and bone morphogenetic proteins, which are secreted from different mesodermal cell types, induce the hepatic gene programme in the endoderm, whereas they inhibit the ...

The firms have teamed up on a Phase I trial to evaluate the off-the-shelf cell therapy SN301A in patients with advanced GPC3-expressing liver cancers.

The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

Medications are dispensed to patients with “liver cancer” through 22 units for the treatment of hepatitis viruses located in national institutes: ministry ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first patient ...

"I put these symptoms off for months before finally going to get a colonoscopy," says Joe Faratzis, who was 28 years old when ...

Scientists in Everett have discovered a way to produce more actinium-225, which they hope will aid in the fight against many ...

Merck & Co., a global pharmaceutical leader, focuses on oncology, immunology, and vaccines. Click here to check out my ...

The integration of nanorobots in drug delivery systems promises precise treatment of diseases, optimizing therapeutic effects ...